2020-12-22,PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
2020-12-16,PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX for the Prevention of Post-Abdominal Surgery Incisional Infections
2020-12-03,PolyPid to Host Key Opinion Leader Call Discussing D-PLEX and the Prevention of Surgical Site Infections
2020-11-24,PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX for the Prevention of Surgical Site Infections in Colorectal Surgery
2020-11-11,PolyPid Ltd. Provides Corporate Update and Reports Third Quarter 2020 Financial Results
2020-11-04,PolyPid to Participate in Three Upcoming Investor Conferences
2020-10-28,"PolyPid to Report Third Quarter 2020 Financial Results and Operational Highlights on November 11, 2020"
2020-10-14,Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
2020-09-28,We Think PolyPid (NASDAQ:PYPD) Can Afford To Drive Business Growth
2020-08-19,PolyPid Ltd. Provides Corporate Update and Reports Second Quarter 2020 Financial Results
2020-08-05,"PolyPid to Report Second Quarter 2020 Financial Results and Operational Highlights on August 19, 2020"
2020-08-03,PolyPid Granted Fast Track Designation from FDA for D-PLEX for Prevention of Surgical Site Infections in Abdominal Surgery
2020-07-27,PolyPid to Present Phase 2 Results of D-PLEX for the Prevention of Surgical Site Infections in Abdominal Surgery at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Conference Recorded Sessions
2020-07-01,PolyPid Initiates First Phase 3 Clinical Trial of D-PLEX100 for the Prevention of Post-Abdominal Surgery Incisional Infections
2020-06-30,PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
2020-06-26,PolyPid Ltd. Announces Pricing of Initial Public Offering
